To the best of our knowledge, there is no study examining the impact of putative genome wide supported psychosis susceptibility NRGN gene on neural substrates such as cortical thickness and other subcortical brain structures such as amygdala, thalamus, basal ganglia in patients suffering from schizophrenia. The gene discussed is NRGN; the disease is schizophrenia.